Benzodiazepine Guide

Clinical Disclaimer: Unlike opioid equipotent dosing, benzodiazepine equivalence is much less evidence-based. Most estimates are based on expert opinion, uncited tables, and clinical practice. Clinical judgment is paramount.

The list of benzodiazepines can be divided into 3 groups based on the duration of action and the speed of the onset of action. This calculator primarily uses duration to categorize medications.

1 Convert Current Drug → Alprazolam Units

If you are taking any medication other than Alprazolam, the calculator first standardizes the dose to Alprazolam Equivalent Units.

Alprazolam Units = Current Dose Current Drug Factor

Example: If taking Diazepam (Factor 15), divide your dose by 15.
Note: If you are already taking Alprazolam, your Factor is 1.

2 Convert Units → Target Drug

Multiply the standardized Alprazolam Units by the factor of the drug you want to switch to.

Target Dose = Alprazolam Units × Target Drug Factor

Example: To switch to Lorazepam (Factor 2), multiply the result from Step 1 by 2.

Clinical Warnings & Limitations

⚠️ Large Dosing Ranges

Due to discrepancies in the literature, many benzodiazepine conversions may have a potential conversion range that is extremely variable (e.g., by a factor of 10x or greater). These wide ranges highlight the lack of firm, evidence-based literature.

⚠️ Patient-Specific Factors

No equipotent conversion considers hepatic function, renal function, age, inter-patient metabolic variability, or drug interactions. Benzodiazepine metabolism can differ significantly; therefore, alterations in drug disposition will alter the relative potencies and durations.

⚠️ Varying Durations of Action

Due to differences in half-life, active metabolites, and drug accumulation, benzodiazepine conversions should account for single-dose versus multiple-dose situations. Currently, no conversion estimates capture this difference accurately.

⚠️ Lack of FDA Oversight

Unlike opioid conversions, the FDA does not require manufacturers to describe equivalent dose or potency of benzodiazepines within the package insert.

Impact of Dosage Forms

Most published conversions are based on oral administration. Parenteral formulations may not use the same conversion ratio. Large variances in oral bioavailability highlight significant inter-patient variability:

Drug Bioavailability
Midazolam40% (range 35-75%)
Lorazepam>90%
Diazepam>90% (range 53-97%)
Phenobarbital>90%

Equivalence & Mode of Action Table

We compare each benzodiazepine to Alprazolam (Factor 1).

Drug Factor (vs Alprazolam) Onset Duration
Alprazolam (Xanax)130 min6-20 h
Lorazepam (Ativan)230-60 min10-20 h
Bromazepam (Lexotan)630m - 4h10-20 h
Midazolam IV (Versed)41-3 min2-4 h
Midazolam PO1010-20 min20m - 3h
Chlordiazepoxide501.5 h5-30 h
Clonazepam (Rivotril)11 h18-39 h
Clorazepate (Tranxene)201 h36-200 h
Diazepam (Valium)1530 min20-50 h
Flurazepam (Dalmane)301 h12-100 h
Oxazepam (Serax)303 h3-21 h
Quazepam (Doral)4020-45 min25-100 h
Temazepam (Restoril)3030-60 min10-20 h
Triazolam (Halcion)0.530 min1.6-5.5 h

Example Calculation

Switching from Diazepam 30mg to Lorazepam:
1. Divide current dose by current factor: 30mg / 15 = 2 (Alprazolam Units)
2. Multiply by target factor: 2 × 2 = 4mg Lorazepam
References
  1. Miller NS, Gold MS. Management of withdrawal syndromes and relapse prevention. Am Fam Physician. 1998.
  2. Quan D. Chapter 177. Benzodiazepines. Tintinalli's Emergency Medicine. 7th ed. 2011.
  3. Ng K, et al. Evaluation of an alcohol withdrawal protocol. Can J Hosp Pharm. 2011.
  4. Sostmann HJ, et al. Dose equivalence of midazolam and triazolam. Eur J Clin Pharmacol. 1989.
  5. Lieberman JA, Tasman A. Handbook of Psychiatric Drugs. 2006.
  6. Ashton H. Benzodiazepines: How they work and how to withdraw; The Ashton Manual. 2002.
  7. UK Clinical Guidelines on Drug Misuse and Dependence Update 2017.
  8. Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr. 2015.
  9. Greenblatt DJ, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology. 1984.
  10. Pentikäinen PJ, et al. Pharmacokinetics of midazolam following IV and oral administration. J Clin Pharmacol. 1989.
  11. Lorazepam [package insert]. Watson Laboratories; 2010.
  12. Dhillon S, et al. Bioavailability of diazepam. Br J Clin Pharmacol. 1982.
  13. Ochs HR, et al. Diazepam absorption. Dig Dis Sci. 1982.
  14. Divoll M, et al. Absolute bioavailability of oral and intramuscular diazepam. Anesth Analg. 1983.
  15. Nelson E, et al. Phenobarbital pharmacokinetics. J Clin Pharmacol. 1982.